Credit Agricole’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $888K | Sell |
3,287
-706
| -18% | -$191K | ﹤0.01% | 841 |
|
|
2024
Q4 | $940K | Buy |
3,993
+1,310
| +49% | +$308K | ﹤0.01% | 851 |
|
|
2024
Q3 | $738K | Buy |
2,683
+110
| +4% | +$30.3K | ﹤0.01% | 779 |
|
|
2024
Q2 | $625K | Buy |
+2,573
| New | +$625K | ﹤0.01% | 734 |
|
|
2021
Q3 | – | Sell |
-150
| Closed | -$25K | – | 597 |
|
|
2021
Q2 | $25K | Hold |
150
| – | – | ﹤0.01% | 501 |
|
|
2021
Q1 | $21K | Buy |
+150
| New | +$21K | ﹤0.01% | 478 |
|
|
2017
Q2 | – | Sell |
-1,613
| Closed | -$83K | – | 1415 |
|
|
2017
Q1 | $83K | Sell |
1,613
-1,703
| -51% | -$87.6K | ﹤0.01% | 1568 |
|
|
2016
Q4 | $125K | Sell |
3,316
-10,030
| -75% | -$378K | ﹤0.01% | 1366 |
|
|
2016
Q3 | $905K | Buy |
13,346
+522
| +4% | +$35.4K | ﹤0.01% | 1165 |
|
|
2016
Q2 | $711K | Buy |
12,824
+642
| +5% | +$35.6K | ﹤0.01% | 1050 |
|
|
2016
Q1 | $765K | Buy |
12,182
+1,270
| +12% | +$79.8K | ﹤0.01% | 977 |
|
|
2015
Q4 | $1.03M | Sell |
10,912
-1,604
| -13% | -$151K | ﹤0.01% | 995 |
|
|
2015
Q3 | $1.01M | Buy |
12,516
+2,018
| +19% | +$162K | 0.01% | 1004 |
|
|
2015
Q2 | $1.26M | Buy |
+10,498
| New | +$1.26M | 0.01% | 980 |
|